Sinofn Health
Sinofn Health
In the complex landscape of cognitive supplements, navigating FDA, EU, and Asian regulations is critical. SINOFN provides full-cycle compliance support, ensuring your private label nootropics meet stringent safety profiles. From raw material sourcing to final batch release, our quality systems (ISO 22000, HACCP) act as your barrier against regulatory non-compliance.
Leveraging the Chinese Academy of Sciences partnership, we offer competitive pricing without sacrificing innovation. Our Shanghai-based hub optimizes logistics, providing a stable supply chain for global enterprises. We turn complex supply chain challenges into predictable, scalable advantages for your brand.
Not all nootropics are created equal. Our R&D team, led by experts from Peking University and international specialists, focuses on delivery technologies. We move beyond basic ingredients to formulate products that maximize absorption and efficacy, directly impacting user satisfaction and retention.
Mrs. GuoHong Liu established SINOFN in 2012. Her dedication to bridging the gap in clinical nutrition drives our "Profit with Purpose" philosophy, ensuring that scientific rigor is applied to every supplement we manufacture.
Supported by the Chinese Academy of Sciences, our team includes Dr. Zhang Ying (CAS Postdoc) and Hans van Dijk (Netherlands formulation specialist). This hybrid of domestic scientific power and international regulatory expertise ensures world-class product development.
We provide localized regulatory consulting, ensuring ingredients and packaging meet specific requirements for markets like the US (FDA/DSHEA), EU (EFSA), and Asia. This reduces risk and speeds up market entry.
We work with both startups and large enterprises. We offer flexible MOQs through our pilot-scale prototyping service, allowing brands to test market viability before full-scale manufacturing.
Yes. Our R&D department specializes in custom formulation, from initial concept to stability testing and mass production, ensuring your unique IP remains protected.
